Pembrolizumab‐associated chronic rhinosinusitis: A new endotype and management considerations.

Authors :: Standiford, Taylor C.
Patel, Neil N.
Singh, Amritpal
Gochman, Grant
Jamie Wu, Tara
Daud, Adil I.
Goldberg, Andrew N.
Source :: International Forum of Allergy & Rhinology. Dec2023, Vol. 13 Issue 12, p2248-2251. 4p.
Publication Year :: 2023
Abstract: KEY POINTS: Patients treated with pembrolizumab experience an increase in paranasal sinus inflammationUse of topical triamcinolone in carboxymethylcellulose is a treatment option for such patients [ABSTRACT FROM AUTHOR]

Subjects :: *SINUSITIS
*PARANASAL sinuses
*NASAL polyps
*CARBOXYMETHYLCELLULOSE
*TRIAMCINOLONE

Full Text Access

Tools